Isracann Biosciences Inc.
ISCNF · OTC
5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $42 | $41 | $45 | $45 |
| Gross Profit | -$42 | -$41 | -$45 | -$45 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,378 | $3,311 | $4,998 | $3,954 |
| SG&A Expenses | $2,506 | $4,893 | $11,729 | $5,618 |
| Sales & Mktg Exp. | $128 | $1,582 | $6,731 | $1,664 |
| Other Operating Expenses | -$113 | $41 | $45 | $0 |
| Operating Expenses | $2,392 | $4,934 | $11,775 | $5,663 |
| Operating Income | -$2,392 | -$4,778 | -$11,177 | -$5,663 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2,301 | -$20,314 | -$12,810 | $63 |
| Pre-Tax Income | -$4,693 | -$25,092 | -$23,988 | -$5,600 |
| Tax Expense | $0 | $31 | -$69 | $0 |
| Net Income | -$4,693 | -$25,155 | -$24,202 | -$9,598 |
| % Margin | – | – | – | – |
| EPS | -0.032 | -0.18 | -0.26 | -0.75 |
| % Growth | 82.3% | 30.8% | 65.3% | – |
| EPS Diluted | -0.032 | -0.18 | -0.26 | -0.75 |
| Weighted Avg Shares Out | 147,753 | 138,580 | 92,758 | 12,772 |
| Weighted Avg Shares Out Dil | 147,753 | 138,403 | 92,758 | 12,772 |
| Supplemental Information | – | – | – | – |
| Interest Income | $94 | $76 | $140 | $63 |
| Interest Expense | $14 | $139 | $0 | $0 |
| Depreciation & Amortization | $42 | $41 | $45 | $45 |
| EBITDA | -$2,392 | -$4,778 | -$11,177 | -$5,275 |
| % Margin | – | – | – | – |